Your browser doesn't support javascript.
loading
Endometrial cancer: predictors and oncological safety of tumor tissue manipulation.
Quintana-Bertó, Raquel; Padilla-Iserte, Pablo; Lago, Víctor; Tauste, Carmen; Díaz-Feijoo, Berta; Cabrera, Silvia; Oliver-Pérez, Reyes; Coronado, Pluvio J; Martín-Salamanca, María Belén; Pantoja-Garrido, Manuel; Marcos-Sanmartin, Josefa; Cazorla, Eduardo; Lorenzo, Cristina; Rodríguez-Hernández, José Ramón; Roldán-Rivas, Fernando; Gilabert-Estellés, Juan; Muruzábal, Juan Carlos; Cañada, Antonio; Domingo, Santiago.
Affiliation
  • Quintana-Bertó R; Department of Gynecologic Oncology, La Fe University and Polytechnic Hospital, València, Spain. raquelqb.25@gmail.com.
  • Padilla-Iserte P; Department of Gynecologic Oncology, La Fe University and Polytechnic Hospital, València, Spain.
  • Lago V; Department of Gynecologic Oncology, La Fe University and Polytechnic Hospital, València, Spain.
  • Tauste C; Department of Gynecologic Oncology, Complejo Hospitalario de Navarra, Navarra, Spain.
  • Díaz-Feijoo B; Institute Clinic of Gynecology, Obstetrics and Neonatology, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
  • Cabrera S; Gynecologic Oncology Unit, Gynecology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Oliver-Pérez R; Gynecologic Oncology-Unit, Department of Obstetrics and Gynecology, University Hospital 12 de Octubre, 12 de Octubre Research Institute, Complutense University of Madrid, Madrid, Spain.
  • Coronado PJ; Women's Health Institute of the Hospital Clínico San Carlos, IdISSC, University Complutense, Madrid, Spain.
  • Martín-Salamanca MB; Gynecology Department, Hospital Universitario de Getafe, Madrid, Spain.
  • Pantoja-Garrido M; Department of Gynecology and Obstetrics, University Hospital Virgen Macarena, Sevilla, Spain.
  • Marcos-Sanmartin J; Department of Obstetrics and Gynecology, Dr. Balmis General University Hospital, Alicante, Spain.
  • Cazorla E; Department of Public Health, Miguel Hernández University, Sant Joan d'Alacant, Alicante, Spain.
  • Lorenzo C; Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.
  • Rodríguez-Hernández JR; Department of Obstetrics and Gynecology, Hospital Universitario de Torrevieja, Alicante, Spain.
  • Roldán-Rivas F; Department of Obstetrics and Gynecology, Hospital Nuestra Señora de La Calendaria, Santa Cruz de Tenerife, Spain.
  • Gilabert-Estellés J; Gynaecology and Obstetrics Department, University Hospital Virgen de La Arrixaca, El Palmar, Murcia, Spain.
  • Muruzábal JC; Department of Obstetrics and Gynaecology, Clinico Lozano Blesa Hospital, Zaragoza, Spain.
  • Cañada A; Department of Obstetrics and Gynecology, University General Hospital of València, València, Spain.
  • Domingo S; Department of Gynecologic Oncology, Complejo Hospitalario de Navarra, Navarra, Spain.
Clin Transl Oncol ; 26(5): 1098-1105, 2024 May.
Article in En | MEDLINE | ID: mdl-37668932
ABSTRACT

PURPOSE:

The main goal of this study is to assess the impact of tumor manipulation on the presence of lympho-vascular space invasion and its influence on oncological results.

METHODS:

We performed a retrospective multi-centric study amongst patients who had received primary surgical treatment for apparently early-stage endometrial cancer. A multivariate statistical analysis model was designed to assess the impact that tumor manipulation (with the use of uterine manipulator or preoperative hysteroscopy) has on lympho-vascular development (LVSI) in the final surgical specimen.

RESULTS:

A total of 2852 women from 15 centers were included and divided into two groups based on the lympho-vascular status in the final surgical specimen 2265 (79.4%) had no LVSI and 587 (20.6%) presented LVSI. The use of uterine manipulator was associated with higher chances of lympho-vascular involvement regardless of the type used Balloon manipulator (HR 95% CI 4.64 (2.99-7.33); p < 0.001) and No-Balloon manipulator ([HR] 95% CI 2.54 (1.66-3.96); p < 0.001). There is no evidence of an association between the use of preoperative hysteroscopy and higher chances of lympho-vascular involvement (HR 95% CI 0.90 (0.68-1.19); p = 0.479).

CONCLUSION:

Whilst performing common gynecological procedures, iatrogenic distention and manipulation of the uterine cavity are produced. Our study suggests that the use of uterine manipulator increases the rate of LVSI and, therefore, leads to poorer oncological results. Conversely, preoperative hysteroscopy does not show higher rates of LVSI involvement in the final surgical specimen and can be safely used.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Transl Oncol Year: 2024 Document type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Language: En Journal: Clin Transl Oncol Year: 2024 Document type: Article Affiliation country: Spain